Attached files

file filename
EX-31 - RULE 13A-14(A) CERTIFICATION - American Nano Silicon Technologies, Inc.americannanoexh31.htm
EX-32 - RULE 13A-14(B) CERTIFICATION - American Nano Silicon Technologies, Inc.americannanoexh32.htm


U. S. Securities and Exchange Commission
Washington, D. C. 20549

FORM 10-Q

 
[X]     QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2015

 
[   ]    TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
 
For the transition period from _________ to ___________

Commission File No. 0-52940

AMERICAN NANO SILICON TECHNOLOGIES, INC.
(Name of Registrant in its Charter)
 
California
33-0726410
(State of Other Jurisdiction of incorporation or organization)
(I.R.S.) Employer I.D. No.)
 
Nanchong Shili Industrial Street, Economic and Technology Development Zone, Xiaolong Chunfei Industrial Park, Sichuan, P.R. China 637005
(Address of Principal Executive Offices)

Issuer's Telephone Number: 86-817-3634888

Indicate  by check mark  whether the  Registrant  (1) has filed all reports required to be filed by Sections 13 or 15(d) of the  Securities Exchange Act of 1934  during  the  preceding  12 months  (or for such shorter  period  that the Registrant was required to file such reports),  and (2) has been subject to such filing requirements for the past 90 days. Yes x   No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.)  Yes x    No o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)   Yes o     No x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check One)

Large accelerated filer o        Accelerated filer o         Non-accelerated filer o        Smaller reporting company x

APPLICABLE ONLY TO CORPORATE ISSUERS:  Indicate the number of shares outstanding of each of the Registrant's classes of common stock, as of the latest practicable date:

Common Voting Stock: 46,917,445 shares as of May 28, 2015
 
 
 

 
  
TABLE OF CONTENTS
 
   
Page No
Part I         Financial Information
 
     
Item 1.
Financial Statements (unaudited):
 
     
 
Consolidated Balance Sheets (Unaudited) – March 31, 2015 and September 30, 2014
2
     
 
Consolidated Statements of Comprehensive Loss (Unaudited) -for the Three and Six Months Ended March 31, 2015 and 2014
3
     
 
Consolidated Statements of Cash Flows (Unaudited) – for the Six Months Ended  March 31, 2015 and 2014
4
     
 
Notes to Consolidated Financial Statements (Unaudited)
5
     
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
12
     
Item 3
Quantitative and Qualitative Disclosures about Market Risk
15
     
Item 4.
Controls and Procedures
16
     
Part II
Other Information
 
     
Item 1.
Legal Proceedings
16
     
Items 1A.
Risk Factors
16
     
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
16
     
Item 3.
Defaults upon Senior Securities
16
     
Item 4.
Mine Safety Disclosures
16
     
Item 5.
Other Information
16
     
Item 6.
Exhibits
16
 
 
1

 

AMERICAN NANO SILICON TECHNOLOGIES, INC. AND SUBSIDIARIES
 
CONSOLIDATED BALANCE SHEETS
 
(Unaudited)  
             
   
March 31
   
September 30,
 
   
2015
   
2014
 
   
 
       
ASSETS
           
Current assets:
           
Cash and cash equivalents
  $ 55,068     $ 97,233  
Accounts receivable, net
    234,533       577,303  
Inventory, net of reserve
    361,227       397,094  
Advance payments
    125,131       137,575  
Prepaid expense and other receivables
    123,447       136,235  
Prepaid value-added tax
    108,101       70,168  
Total Current Assets
    1,007,507       1,415,608  
                 
Property, plant and equipment, net
    19,913,526       20,545,631  
                 
Other assets:
               
Land use rights, net
    976,546       986,449  
Total other assets
    976,546       986,449  
                 
Total Assets
  $ 21,897,579     $ 22,947,688  
                 
LIABILITIES AND STOCKHOLDERS' (DEFICIENCY) EQUITY
               
                 
Current liabilities:
               
Accounts payable
  $ 418,132     $ 234,686  
Short term loans
    11,463,891       10,096,451  
Taxes payable
    114,763       114,435  
Due to related parties-current portion
    3,563,897       3,165,014  
Long term loans-current portion
    6,200,554       1,508,465  
Accrued expenses and other payables
    1,437,223       1,136,888  
                 
Total Current Liabilities
    23,198,460       16,255,939  
                 
Long-term liabilities
               
Long term loans
    -       4,766,471  
Total Long Term Liabilities
    -       4,766,471  
                 
Total Liabilities
    23,198,460       21,022,410  
                 
Stockholders' (Deficiency) Equity
               
           
Common stock, $0.0001 par value, 200,000,000 shares authorized; 46,917,445 shares issued and outstanding as of March 31, 2015 and September 30, 2014, respectively     4,692        4,692   
Additional paid-in-capital
    14,772,979       14,640,456  
Accumulated other comprehensive income
    2,296,550       2,297,685  
Accumulated deficit
    (18,375,102 )     (15,017,555 )
Total  Stockholders' (Deficiency) Equity
    (1,300,881 )     1,925,278  
                 
Total Liabilities and Stockholders' (Deficiency) Equity
  $ 21,897,579     $ 22,947,688  
 
The accompanying notes are an integral part of these unaudited consolidated financial statements.
 
 
2

 
 
AMERICAN NANO SILICON TECHNOLOGIES, INC. AND SUBSIDIARIES
 
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
 
   
(Unaudited)
                   
                         
   
For the Three Months Ended
   
For the Six Months Ended
 
   
March 31,
   
March 31
 
   
2015
   
2014
   
2015
   
2014
 
                         
Revenues
  $ 145,971     $ 244,654     $ 936,110     $ 590,524  
                                 
Cost of Goods Sold
    590,899       643,743       1,719,732       1,393,703  
                                 
Gross Loss
    (444,928 )     (399,089 )     (783,622 )     (803,179 )
                                 
Operating Expenses
                               
Research and development expense
    -       81,664       -       98,147  
Selling, general and administrative
    279,864       313,941       544,347       558,609  
Total operating expense
    279,864       395,605       544,347       656,756  
                                 
Loss from operations
    (724,792 )     (794,694 )     (1,327,969 )     (1,459,935 )
                                 
Other Income( Expense)
                               
Interest expense - related party
    (101,250 )     (53,887 )     (164,666 )     (268,776 )
Interest expense, net
    (1,159,287 )     (819,879 )     (1,919,313 )     (1,185,214 )
Other income
    47,474       1,555       54,401       3,532  
Total other income(expense)
    (1,213,063 )     (872,211 )     (2,029,578 )     (1,450,458 )
                                 
Loss  Before  Income Taxes
    (1,937,855 )     (1,666,905 )     (3,357,547 )     (2,910,393 )
                                 
Provision for Income Taxes
    -       43       -       141  
                                 
Net Loss
    (1,937,855 )     (1,666,948 )     (3,357,547 )     (2,910,534 )
Other Comprehensive Loss
                               
Foreign currency translation adjustment
    (6,398 )     (49,480 )     (1,135 )     (1,612 )
Comprehensive Loss
  $ (1,944,253 )   $ (1,716,428 )   $ (3,358,682 )   $ (2,912,146 )
                                 
Loss per common share
                               
Basic and diluted
  $ (0.04 )   $ (0.04 )   $ (0.07 )   $ (0.06 )
                                 
Weighted average number of common shares
                               
Basic and diluted
    46,917,445       46,917,445       46,917,445       46,917,445  
 
The accompanying notes are an integral part of these unaudited consolidated financial statements.
 
 
3

 

 AMERICAN NANO SILICON TECHNOLOGIES, INC. AND SUBSIDIARIES
 
  CONSOLIDATED STATEMENTS OF CASH FLOWS
 
 (Unaudited)
 
             
   
Six Months Ended March 31,
 
   
2015
   
2014
 
             
 Cash Flows From Operating Activities:
           
 Net Loss
  $ (3,357,547 )   $ (2,910,534 )
 Adjustments to reconcile net loss to net cash used in operating activities:
               
 Inventory markdown
    54,098       -  
 Depreciation and amortization
    777,131       743,359  
 Imputed interest expense for non interest bearing related party loans
    132,522       124,222  
 Changes in operating assets and liabilities:
               
 Accounts receivable
    344,014       77,602  
 Inventory
    (16,885 )     (21,390 )
 Advances to suppliers
    12,909       121,044  
 Prepaid expense and other receivables
    13,248       (7,403 )
 Prepaid value-added tax
    (37,587 )     (9,303 )
 Accounts payable
    182,149       (95,913 )
 Taxes payable
    (86 )     (18,691 )
 Accrued expenses and other payables
    295,638       (128,114 )
 Cash used in operating activities
    (1,600,396 )     (2,125,121 )
                 
 Cash Flows From Investing Activities:
               
 Additions to property and equipment
    (58,952 )     (270,415 )
                 
 Cash used in investing activities
    (58,952 )     (270,415 )
                 
 Cash Flows From Financing Activities
               
 Proceeds (repayment) of related parties loans, net
    386,477       (3,245,907 )
 Proceeds from short term loans, net
    1,327,632       2,125,023  
 Repayment of long term loans, net
    (96,495 )     3,751,455  
 Cash provided by financing activities
    1,617,614       2,630,571  
                 
 Effect of exchange rate changes on cash and cash equivalents
    (431 )     (1,867 )
                 
 Increase(decrease) in cash and cash equivalents
    (42,165 )     233,168  
                 
 Cash and Cash Equivalents - Beginning of the period
    97,233       75,901  
                 
 Cash and Cash Equivalents - End of the period
  $ 55,068     $ 309,069  
                 
 SUPPLEMENTAL CASH FLOW INFORMATION:
               
 During the period, cash was paid for the following:
               
 Interest expense
  $ 1,605,471     $ 1,299,232  
 Income tax
  $ -     $ 141  
 
The accompanying notes are an integral part of these unaudited consolidated financial statements.
 
 
4

 
 
AMERICAN NANO SILICON TECHNOLOGIES, INC.
Notes to Consolidated Financial Statements
(Unaudited)


Note 1 – Organization and Nature of Business

American Nano-Silicon Technologies, Inc. (the “Company” or “ANNO”) was incorporated in the State of California on September 6, 1996. Since 2006, the Company has been primarily engaged in the business of manufacturing and distributing refined consumer chemical products through its subsidiaries, Nanchong Chunfei Nano-Silicon Technologies Co., Ltd. (“Nanchong Chunfei”), Sichuan Chunfei Refined Chemicals Co., Ltd. (“Chunfei Chemicals”), and Sichuan Hedi Veterinary Medicines Co., Ltd. (“Hedi Medicines”).
 
On May 28, 2013, the Company assigned 10% of the equity in Chunfei Chemicals to each of Mr. Fachun Pu, Mr. Qiwei Zhang and Mr. Jianbo Liu, and assigned 5% of the equity in Hedi Medicines to  Mr. Fachun Pu, and the assignees paid to the Company cash equal to the registered equity amount.  At the same time, Messrs Pu, Zhang and Liu agreed to hold those equity interests solely for the benefit of the Company, to pay over to the Company any distributions or dividends they receive, to vote their interests as directed by the Company, and to resell the interests to the Company at its option for cash equal to the registered equity amount.
 
Note 2 – Summary of Significant Accounting Policies

Basis Of Presentation and Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

The unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the unaudited financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position as of March 31, 2015 and the results of operations and cash flows for the six month periods ended March 31, 2015 and 2014. The financial data and other information disclosed in these notes to the interim financial statements related to these periods are unaudited. The results for the six months ended March 31, 2015 are not necessarily indicative of the results to be expected for any subsequent periods or for the entire year ending September 30, 2015. The balance sheet at September 30, 2014 has been derived from the audited financial statements at that date.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to the Securities and Exchange Commission’s rules and regulations. These unaudited financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended September 30, 2014 as included in our Annual Report on Form 10-K.

Reclassifications

Certain amounts of prior period were reclassified for presentation purposes.
 
Fair Value of Financial Instruments

The Company adopted the provisions of Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1- Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.
 
 
5

 
 
AMERICAN NANO SILICON TECHNOLOGIES, INC.
Notes to Consolidated Financial Statements
(Unaudited)


Note 2 – Summary of Significant Accounting Policies (Continued)

Level 2- Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

Level 3- Inputs are unobservable inputs which reflect the reporting entity’s own assumptions.

The carrying amounts reported in the balance sheets for cash, accounts receivable, inventory, taxes payable, due to related parties, prepaid expenses, other receivables, advance to suppliers, short-term loan, accounts payable,  other payables and accrued expenses approximate their fair market value based on the short-term nature of these instruments. The carrying value of the long-term debt approximates fair value based on market rates and terms currently available to the Company. The Company did not identify any assets or liabilities that are required to be presented on the consolidated balance sheet at fair value in accordance with ASC 820.

Taxation

Income Taxes

The Company accounts for income tax under the provisions of ASC 740-10-25, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the events that have been included in the financial statements or tax returns. Deferred income taxes are recognized for all significant temporary differences between tax and financial statements bases of assets and liabilities. Valuation allowances will also be established against net deferred tax assets when it is more likely than not that some portion or all of the deferred tax asset will not be realized.
 
Uncertain Tax Positions

During the course of business, there are certain transactions and calculations for which the ultimate tax determination is uncertain. We establish reserves for tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes may be due. These reserves are established when we believe that certain positions might be challenged despite our belief that our tax return positions are fully supportable. We adjust these reserves in light of changing facts and circumstances, such as the outcome of a tax audit or changes in the tax law. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate.

Value Added Tax

Value added tax is imposed on goods sold in or imported in the PRC. Value added tax payable in the People’s Republic of China is charged on an aggregated basis at a rate of 13% or 17% (depending on the type of goods involved) on the full price collected for the goods sold or, in the case of taxable services provided, at a rate of 17% on the charges for the taxable services provided, but excluding, in respect of both goods and services, any amount paid in respect of value added tax included in the price or charges, and less any deductible value added tax already paid by the taxpayer on purchases of goods and services in the same financial year.
 
Earnings (Loss) Per Share

Earnings per share are calculated in accordance with the FASB ASC 260, “Earnings per share.” Basic earnings per share are based upon the weighted average number of common shares outstanding, but excluding shares issued as compensation that have not yet vested. Diluted earnings per share are based on the assumption that all dilutive convertible shares and stock options were converted or exercised, and that all unvested shares have vested. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

 
6

 
 
AMERICAN NANO SILICON TECHNOLOGIES, INC.
Notes to Consolidated Financial Statements
(Unaudited)


Note 2 – Summary of Significant Accounting Policies (Continued)
 
Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of  accounts receivable, advances to suppliers and other receivables arising from its normal business activities. The Company does not require collateral or other security to support these receivables. The company routinely assesses the financial strength of its debtors and, based upon factors surrounding the credit risk, establishes an allowance, if required, for uncollectible accounts.

Foreign Currency Translation

The Company’s principal country of operations is the PRC. The financial position and results of operations of the Company are determined using the local currency, Renminbi (“RMB”), as the functional currency. Foreign currency transactions are translated at the applicable rates of exchange in effect at the transaction dates. Monetary assets and liabilities denominated in foreign currencies at the balance sheet date are translated at the applicable rates of exchange in effect at that date. Revenues and expenses are translated at the average exchange rates in effect during the reporting period. Equity accounts are translated in the historical exchange rate when the transactions took place.

Asset and liability accounts at March 31, 2015 and September 30, 2014 were translated at 6.1312 RMB to $1.00 and at 6.1534 RMB to $1.00, respectively, which were the exchange rates on the balance sheet dates. Equity accounts were stated at their historical rate. The average translation rates applied to the statements of income and cash flows for the six months ended March 31, 2015 and 2014 were 6.1463 RMB and 6.1237 RMB to $1.00, respectively.

RMB is not a fully convertible currency. All foreign exchange transactions involving RMB must take place either through the People’s Bank of China (the “PBOC”) or other institutions authorized to buy and sell foreign exchange. The exchange rates adopted for the foreign exchange transactions are the rates of exchange quoted by the PBOC, which are determined largely by supply and demand.

Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders' equity as "Accumulated Other Comprehensive Income". Gain or loss from translation adjustments is included in the statement of operations.

Note 3 – Going Concern

As shown in the accompanying financial statements, the Company’s current liabilities exceed its current assets by $22.2 million as of March 31, 2015. The current cash and inventory level will not be sufficient to support the Company’s operations and repayments of the loans. In addition, the Company has suffered negative gross profit and negative cash flows from its operations for the past two years. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The Company will need additional funds to meet its operating and financing obligations until sufficient cash flows are generated from anticipated production to sustain operations and to fund future development and financing obligations. We expect, but provide no assurance, that affiliate companies owned by the Company’s largest shareholder and president, Mr. Pu Fachun, will continue to provide necessary funding for the Company’s normal operations. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 
7

 
 
AMERICAN NANO SILICON TECHNOLOGIES, INC.
Notes to Consolidated Financial Statements
(Unaudited)


Note 4 – Inventory

The inventory as of March 31, 2015 and September 30, 2014 consisted of the following:
 
   
March 31,
2015
   
September 30,
2014
 
             
Raw materials
 
$
88,297
   
$
125,338
 
Packing supplies
   
79,484
     
70,126
 
Work in process
   
89,525
     
75,199
 
Finished goods
   
103,921
     
126,431
 
    Total
 
$
361,227
   
$
397,094
 
 
Note 5 – Related Party Transactions

The Company periodically borrows money from its shareholders to finance the operations.  These loans are all due on demand. The details of loans from related parties are as follows:
 
   
March 31,
2015
   
September 30,
2014
 
             
Short term:
           
Sichuan Chunfei Real Estate
 
$
670,050
   
$
1,212,670
 
Sichuan Chunfei Daily Chemical
   
1,750,556
     
755,759
 
Sichuan Shubei Feed Co.Ltd.
   
63,120
     
62,891
 
Zhang, Qiwei, a shareholder
   
34,251
     
-
 
Pu Fachun, Chief Executive Officer
   
1,045,920
     
1,133,694
 
   Total
 
$
3,563,897
   
$
3,165,014
 

Sichuan Chunfei Daily Chemicals Co. Ltd (“Daily Chemical”) and Sichuan Chunfei Real Estate (“Chunfei Real Estate”) are owned by Mr. Pu Fachun. Sichuan Shubei Feed Co.Ltd. is owned by Mr. Pu Xidi, son of Mr. Pu Fachun.

The Company recorded imputed interest at 6% per annum and recorded $69,035 and $132,522 for non-interest bearing related party loans for the three and six months ended March 31, 2015, respectively.

The Company recorded imputed interest at 6% per annum and recorded $42,551 and $124,222 for non-interest bearing related party loans for the three and six months ended March 31, 2014, respectively.

Interest expense for interest-bearing related party loans was $32,215 and $32,144 for the three and six months ended March 31, 2015, respectively.

Interest expense for interest-bearing related party loans was $11,336 and $144,554 for the three and six months ended March 31, 2014, respectively.

The following table summarized related party loans with interest and non interest as of March 31, 2015:

   
Non
interest
bearing
   
Bearing
interest from
1%-2.3% per 
month
 
Short term loan
 
$
2,944,117
   
$
619,780
 
Long term loan
   
-
     
-
 
   
$
2,944,117
   
$
619,780
 
 
 
8

 
 
AMERICAN NANO SILICON TECHNOLOGIES, INC.
Notes to Consolidated Financial Statements
(Unaudited)
 
 
Note 6 – Short Term Loans and Long Term Loans

The short term loans as of March 31, 2015 and September 30, 2014 consisted of the following:
 
     
March 31,
2015 
     
September 30,
2014
 
                 
a) Loan payable to Nanchong City Bureau of Finance due on demand, fixed interest rate of 0.465% per month
 
$
-
   
$
650,047
 
                 
b) Loan payable to Nanchong Commercial Bank, due on March 7, 2015, at a fixed interest rate of 6.9% per annum, guaranteed by a third party       -         812,559  
                 
c)Loan payable to Nanchong Commercial Bank, due on  July 23, 2015, at a fixed interest rate of 6.9% per annum, guaranteed by a third party
   
815,500
     
812,559
 
                 
d)Loan payable to Nanchong Commercial Bank, due on March 23, 2016, at a fixed interest rate of 6.1525% per annum, guaranteed by a third party
   
815,500
     
-
 
                 
e)Loan payable to Bank of Communications due on July 27, 2015, at an interest rate of 7.8% per annum and  guaranteed by a third party  and Mr. Pu, Chairman and CEO of the Company
   
815,500
     
812,559
 
               
f) Individual loans from unrelated parties, which are due on demand and bearing a weighted average interest rate of 2.68% per month
   
9,017,391
     
7,008,727
 
                 
Total Short Term Loans
 
$
11,463,891
   
$
10,096,451
 
                 
a) Individual loans from unrelated parties bearing a weighted average interest rate of 2.73% per month
   
1,370,654*
     
1,462,094
 
                 
b) Individual loans from various investors, bearing interest of 12% per annum and due on July 1, 2015, as extended
   
100,000
   
100,000
 
                 
c)Loan payable to Jialing Rural Credit Cooperative Union due on December 19, 2015 at an interest rate of 10.764% per annum, secured by Chunfei Chemical’s real property and Chunfei Real Estate’s real property
   
4,729,900 
     
4,712,842  
 
                 
Less: current portion of long term loans
   
(6,200,554) 
     
(1,508,465) 
 
                 
Total Long Term Loans
 
$
-
   
$
4,766,471
 

*Loans in the amount of $19,371 will be due on August 12, 2015. Loans in the amount of $1,351,283 are due on demand.

The Company pledged its land use right and its building and equipment to a third party to secure the bank loans. The Company recorded interest expense of $1,159,287 and $1,919,313 for the three and six months ended March 31, 2015, respectively. The Company recorded interest expense of $819,879 and $1,185,214 for the three and six months ended March 31, 2014, respectively.
 
 
9

 
 
AMERICAN NANO SILICON TECHNOLOGIES, INC.
Notes to Consolidated Financial Statements
(Unaudited)
 
 
Note 7 – Income Taxes

The Company’s subsidiaries are governed by the Income Tax Law of the People’s Republic of China.  Their income is taxed at the 25% statutory rate. Hedi Medicine has been taxed at a flat rate of 260 RMB per quarter since calendar 2012.

The following table reconciles the U.S. statutory rates to the Company’s effective tax rate for the six months ended March 31, 2015 and 2014:

   
Six months Ended March 31
 
   
2015
   
2014
 
                 
US statutory income tax rate
   
35
%
   
35%
 
Non-taxable item in US
   
0
%
   
0%
 
Change in valuation allowance - US
   
-35
%
   
-35%
 
China income tax statutory statutory rate
   
25
%
   
25%
 
Change in valuation allowance - China
   
-25
%
   
-25%
 
Effective rate
   
-
     
-
 
 
As of March 31, 2015, net operating loss carry forwards for United States and China income tax purposes amounted to $2.5 million and $20 million, which may be available to reduce future years' taxable income. These carry forwards will expire, if not utilized, beginning in 2028 through 2034 for U.S tax purpose and 2019 to 2020 for China income tax purposes. Management believes that the realization of the benefits arising from the losses recognized in the US is uncertain due to the Company's business operations being primarily conducted in China and foreign income not being recognized in the United States for federal income tax purposes. It is also uncertain that the China business operations will generate taxable income in the future. Accordingly, the Company has provided a 100% valuation allowance as of the balance sheet dates, for the temporary differences related to the loss carry-forwards.

The following table reconciles the changes in deferred tax asset for the six months ended March 31, 2015 and 2014:
 
   
March 31,
2015
   
March 31,
2014
 
United States:
           
Deferred tax asset-beginning
 
$
872,859
   
$
855,293
 
Addition: loss carry-forward
   
7,815
     
10,651
 
Valuation allowance-beginning
   
(872,859
)
   
(855,293)
 
Addition: valuation allowance
   
(7,815
)
   
(10,651)
 
Deferred tax asset net
 
$
-
   
$
     -
 

   
March 31,
2015
   
March 31,
2014
 
China:
           
Deferred tax asset -beginning
  $ 3,663,881     $ 2,084,623  
Addition: loss carry-forward
    833,805       719,990  
Valuation allowance-beginning
    (3,663,881 )     (2,084,623 )
Addition: valuation allowance
    (833,805 )     (719,990 )
Deferred tax asset- net
  $ -     $ -  

The Company’s open tax years for its federal and state income tax returns are for the tax years after 2011. These tax returns are subject to examination by the tax authorities.

 
10

 
 
AMERICAN NANO SILICON TECHNOLOGIES, INC.
Notes to Consolidated Financial Statements
(Unaudited)
 
 
Note 8 – Concentration

For the three months ended March 31, 2015, two customers accounted for 69% and 21% of total sales, respectively.  For the six months ended March 31, 2015, two customers accounted for 44% and 44% of total sales, respectively.

For the six months ended March 31, 2014, two customers accounted for 73% and 10% of total sales. For the three months ended March 31, 2014, once customer accounted for 80% of total sales.

Note 9 – Commitment and Contingencies
 
LITIGATION

During the 2013 fiscal year, Jian Zhou, a shareholder, commenced a legal action against American Nano Silicon Technologies, Inc.  in the PRC. Mr. Zhou alleges that he is entitled to 857,142 shares of American Nano common stock in connection with the acquisition of Nanchong Chunfei by American Nano in 2007.  In response to the allegation, American Nano has asserted that all of the shares to which Mr. Zhou was entitled were issued to him. The trial court has dismissed Mr. Zhou’s claim, and he has appealed the dismissal to the court of appeals.

NOTE 10–SUBSEQUENT EVENTS

The Company has evaluated subsequent events for purposes of recognition or disclosure through the date these financial statements were issued, and has determined that there was no material event that occurred subsequent to March 31, 2015 which would require adjustments to or disclosure in the financial statements.

 
11

 
 
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT OF OPERATIONS

Forward Looking Statements

This Quarterly Report on Form 10-Q contains "forward-looking" statements as such term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements contain information relating to the Company that is based on the beliefs of the Company’s management as well as assumptions made by and information currently available to the Company’s management. When used in this report, the words “anticipate,” “believe,” “estimate,” “expect” and “intend” and words or phrases of similar import, as they relate to the Company or Company management, are intended to identify forward-looking statements. Such statements reflect the current risks, uncertainties and assumptions related to certain factors including, without limitations, competitive factors, general economic conditions, customer relations, relationships with vendors, the interest rate environment, governmental regulation and supervision, seasonality, distribution networks, product introductions and acceptance, technological change, changes in industry practices, onetime events and other factors. Factors that might cause such forward-looking statements to prove inaccurate include, but are not limited to, those discussed in Item 1A entitled “Risk Factors” of our Annual Report on Form 10-K for the year ended September 30, 2014. Based upon changing conditions, should any one or more of these risks or uncertainties materialize, or should any underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected or intended. The Company assumes no obligation to update these forward-looking statements.
 
Restructuring of our Operations
 
In May 2011, the Company began moving to its new factory site located at Nanchong Shili Industrial Street, Economic and Technology Development Zone, Xiaolong Chunfei Industrial Park, which is approximately 12.4 miles from the Company's previous factory site. We expect the new site to provide us an annual manufacturing capacity of approximately 10 million tons. The Company temporarily suspended production to facilitate the move, resulting in a significant decrease in sales beginning in the third quarter of fiscal year 2011. On December 8, 2011, the Company announced that it had successfully relocated to its new facility in Nanchong, Sichuan, China. In addition to housing existing equipment and machinery from its previous facility, ANNO’s latest facility also contains new equipment that enables the Company to increase its product diversification capabilities as well as manufacture its new flame retardant additive product.
 
Flame retardant additive is a new refined chemical product for the Company, which has very strict standards. We began trial production of the product on January 2, 2012 and during calendar year 2012  conducted several rounds of testing of the quality of the product by asking potential customers for trial use. Through calendar year 2012 we were recalibrating our production process according to feedback received from potential customers. By December 2012 we had satisfied ourselves regarding the quality of our new manufacturing systems, so during 2013 we initiated efforts to market a relatively low-cost flame retardant to the electric cable industry.  We discovered, however, that demand by the cable industry for our product disappeared at our price point, and so we were forced to sell at unprofitable prices. Therefore, we now only manufacture the flame retardant additive when we receive a product order. During 2014, the Company resumed full operation of Micro Nano Silicon™.  During the six months ended March 31, 2015, the Company recorded $855,320 of revenue from Micro Nano Silicon™ and $53,904 of revenue from flame retardant additive. The remainder of our revenue was related to our detergent.
 
Critical Accounting Policies
 
Our consolidated financial information has been prepared in accordance with U.S. GAAP, which requires us to make judgments, estimates and assumptions that affect (1) the reported amounts of our assets and liabilities, (2) the disclosure of our contingent assets and liabilities at the end of each fiscal period and (3) the reported amounts of revenues and expenses during each fiscal period. We continually evaluate these estimates based on our own historical experience, knowledge and assessment of current business and other conditions, our expectations regarding the future based on available information and reasonable assumptions, which together form our basis for making judgments about matters that are not readily apparent from other sources. Some of our accounting policies require a higher degree of judgment than others in their application.
 
 
12

 
 
When reviewing our consolidated financial statements, the following should also be considered: (1) our selection of critical accounting policies, (2) the judgment and other uncertainties affecting the application of those policies, and (3) the sensitivity of reported results to changes in conditions and assumptions. In our preparation of the accompanying consolidated financial statements for the six months ended March 31, 2015, there was one estimate made which was (a) subject to a high degree of uncertainty and (b) material to our results.  This was:

·
our determination, described in Note 7 to the financial statements, to record a 100% allowance for our deferred tax assets.  The determination to record the allowance with respect to our U.S. deferred tax assets was based on the uncertainty that we would realize income taxable in the U.S. in future years.  The determination with respect to our China deferred tax assets was based on the uncertainty that we would realize sufficient income within the requisite time period to utilize the deferred asset.

Results of Operations
 
Revenues and Gross Profit/Loss

We generated revenue of $145,971 and $936,110 during the three and six months ended March 31, 2015 compared to $244,654 and $590,524 in the three and six months ended March 31, 2014, a decrease of 40% for the three month period and an increase of 58.5% for the six month period. Revenue decreased in the three months ended March 31, 2015 because the Company was short of cash flow and the cost of raw materials was high during the three months ended March 31, 2015, which had negative impact on the Company’s sales. Revenue significantly increased in the six months ended March 31, 2015 because the Company had only started partial operations in 2013 and gradually resumed commercial-scale production of Micro SiliconTM during 2014.

The following table shows the contribution to revenue by our three core product lines:

   
Three Months Ended March 31
   
Six Months Ended March 31
 
   
2015
   
2014
   
2015
   
2014
 
Micro Nano Silicon™
  $ 99,674     $ 204,421     $ 855,320     $ 446,798  
Detergent
    12,371       13,152       26,886       30,400  
Flame Retardant Additive
    33,926       27,081       53,904       113,326  
Total Revenue
  $ 145,971     $ 244,654     $ 936,110     $ 590,524  

Our factory has a production capacity of 10 million tons.  During fiscal 2014 we only resumed full operation in the production of Micro Nano Silicon™. As a result of this failure to utilize the capacity of our facilities, our operations are very inefficient.  Our gross loss for the three months ended March 31, 2015 and 2014, therefore, were $444,928 and $399,089, respectively. Our gross loss for the six months ended March 31, 2015 and 2014 were $783,622 and 803,179, respectively.   We will continue to operate at an unprofitable level until we secure sufficient working capital to enable us to approach full production.

 Selling, General and Administrative Expenses
 
Our selling, general and administrative, or SG&A, expenses include expenses associated with salaries and other expenses related to marketing and administrative activities. In addition, we have incurred expenses through the use of consultants and other outsourced service providers to take advantage of specialized knowledge and capabilities that we require for short periods of time to avoid unnecessary hiring of full-time staff.
 
Our SG&A expenses for the three and six months ended March 31, 2015 were $279,864 and $544,347, compared to $313,941 and $558,609 for the three and six months ended March 31, 2014, a decrease of 11% and 3% for the three and six months periods. The decrease in SG&A expenses for the three months ended March 31, 2015 as compared to 2014 was attributed to the decrease in shipping expense that accompanied the decrease in our sales. The decrease in SG&A expenses for the six months ended March 31, 2015 was mainly due to more strict control on expenditure because of tight cash flow.

 
13

 
 
Research and Development Expenses
 
Our business model is based upon developing additional uses for Micro Nano Silicon. Our research and development activities are focused on developing such uses as well as developing nano filtering technology and the production processes for our product. 

Since 2011, the focus of our operations has been the move to a new facility. This has distracted us from our research and development activities.  Therefore, during the six months ended March 31, 2015, we incurred no expenses related to  research and development.  During the three and six months ended March 31, 2014, we incurred $81,664 and $98,147, respectively, in research and development expenses. Research and development expenses have been particularly low in these periods as we focused entirely on initiating the manufacturing of our new product, flame retardant additive.

We believe that the future success of our business depends upon our ability to improve our production processes and develop other uses for Micro Nano Silicon.  To avoid product obsolescence, we will continue to monitor technological changes in our industry as well as users' demands for new products. Failure to keep pace with future technological changes could adversely affect our revenues and operating results in the future.  Although we believe that Micro Nano Silicon can be utilized in a number of industries, there can be no assurance that we will gain market acceptance of our products in such industries.
 
Other Income and Expense
 
As a result of the factors discussed above, we recorded a loss from operations of $724,792 and $1,327,969 during the three and six months ended March 31, 2015,  compared to $794,694 and $1,459,935 for the three and six months ended March 31, 2014.  In all periods, however, non-operating income and expense had a significant effect on our net income.

The primary element of Other Income and Expense during the three and six months ended March 31, 2015 was interest expense relating to loans from bank, unrelated parties and related parties.  Interest expense was $1,260,537 and $2,083,979 for the three and six months ended March 31, 2015, an increase of 44% and 43% compared to the same periods ended March 31, 2014, as we paid interest expenses related to a government loan due on demand that was paid on February 28, 2015.

Net Loss
 
Due, primarily, to our gross loss and interest expense, we incurred a net loss of $1,937,855 and $3,357,547 for the three and six months ended March 31, 2015, compared to net loss of $1,666,948 and $2,910,534 for the three and six months ended March 31, 2014.   Once we start to market our high-end flame retardant additive, we believe that the top line benefits will more than compensate for the increased expenses, and we will realize income from operations in future periods.  

Liquidity and Capital Resources
 
   
March 31,
2015
   
September 30,
2014
 
                 
Total current assets
 
$
1,007,507
   
$
1,415,608
 
Total current liabilities
   
23,198,460
     
16,255,939
 
Working capital (deficiency)
 
$
(22,190,953)
   
$
(14,840,331)
 

At March 31, 2015 we had a working capital deficiency of $22,190,953, representing an increase of $7,350,622 in the deficit during the six months ended March 31, 2015.  In addition to our net loss for the quarter, the primary cause of the increase in working capital deficit was the reclassification of approximately $4.7 million in bank loans from long-term to current liabilities.

 
14

 
 
Our current assets on March 31, 2015 were only $1,007,507, of which only $650,828 were liquid.   Our current liabilities are primarily composed of short term loans totaling $11,463,891, short term related parties payables totaling $3,563,897 due to Mr. Pu Fachun and entities owned by Mr. Pu Fachun, the single largest shareholder and president of the Company, and $6,200,554 being the current portion of our long term loans. Due to our negative cash flow and working capital deficit, our auditors expressed substantial doubt about the Company’s ability to continue as a going concern in the audit report on our financial statements for the year ended September 30, 2014.
 
The following tables summarize our contractual obligations as of March 31, 2015, and the effect these obligations are expected to have on our liquidity and cash flows in future periods.

   
Payments due by period
 
   
Total
   
Less than
1 year
   
1-3
Years
   
3-5
Years
   
5+
Years
 
                               
Related parties indebtedness
 
$
3,563,897
   
$
3,563,897
   
$
-
   
$
-
   
$
-
 
Loan payable to unrelated parties
   
17,664,445
     
17,664,445
     
-
     
-
     
-
 
Total contractual obligations
 
$
21,228,342
   
$
21,228,342
   
$
-
   
$
-
   
$
-
 
  
Our operations used $1,600,396 in cash during the six months ended March 31, 2015. Our use of cash fell short of our net loss of $3,357,547, as the net loss included depreciation and amortization expense of $777,131 and imputed interest of $132,522.

Our operations used $2,125,121 in cash during the six months ended March 31, 2014. Our use of cash fell short of our net loss of $2,910,534, as the net loss included depreciation and amortization expense of $743,359 and imputed interest of $124,222.

For the six months ended March 31, 2015 and 2014, we used $58,952 and $270,415 in investing activities, consisting of additions to property and equipment. 

Our financing activities in the six months ended March 31, 2015 provided cash of $1,617,614 including proceeds of $386,477 from related parties loans, proceeds of $1,327,632 from short term loans net of repayment of long term loans of $96,495.

Our financing activities in the six months ended March 31, 2014 included proceeds of $2,125,023 from short-term loans and proceeds from long term loans of 3,751,455. From those proceeds, we used $3,245,907 to repay a portion of the sums we have borrowed from related parties.

As of the date of this report, we do not have sufficient cash to operate for the next 12 months.  We expect, but provide no assurance, that affiliate companies owned by the Company’s largest shareholder and president, Mr. Pu Fachun, will continue to provide necessary funding for the Company’s normal operations.
 
Off-balance Sheet Arrangements
 
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition or results of operations.

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
Not applicable.
 
 
15

 
 
ITEM 4.  CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

As of March 31, 2015, we carried out an evaluation, under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934. Based upon that evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures are not effective in enabling us to record, process, summarize and report information required to be included in our periodic SEC filings within the required time period, due to the lack of expertise in U.S. GAAP accounting among the personnel in our accounting department.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II   -   OTHER INFORMATION
 
Item 1.   
Legal Proceedings
 
None.
  
 
Item 1A
Risk Factors
 
There have been no material changes from the risk factors included in the Annual Report on Form 10-K for the year ended September 30, 2014.
    
 
Item 2
Unregistered Sale of Securities and Use of Proceeds
   
 
(a) Unregistered sales of equity securities
               
The Company did not effect any unregistered sale of equity securities during the second quarter of fiscal 2015.
   
 
(c) Purchases of equity securities
                
The Company did not repurchase any of its equity securities that were registered under Section 12 of the Securities Exchange Act during the second quarter of fiscal 2015.
      
 
Item 3.    
Defaults Upon Senior Securities.
                
None.
    
 
Item 4.    
Mine Safety Disclosures.
 
Not Applicable.
   
Item 5.    
Other Information.
                
None.
 
 
16

 
 
Item 6.    
Exhibits

31
Rule 13a-14(a) Certification
   
32
Rule 13a-14(b) Certification
   
101.INS
XBRL Instance
   
101.SCH
XBRL Schema
   
101.CAL
XBRL Calculation
   
101.DEF
XBRL Definition
   
101.LAB
XBRL Label
   
101.PRE
XBRL Presentation
 
 
SIGNATURES

Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the Registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the undersigned thereunto duly authorized.

 
American Nano Silicon Technologies, Inc.
 Date : May 28, 2015
 
 /s/Pu Fachun
 
 Pu Fachun, Chief Executive Officer
 
 and Chief Financial and Accounting Officer
 
 
17